Protalix BioTherapeutics, Inc. (PLX)

Last Year

02-May-23 -- 01-May-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

22

0

4

+1

0

+2

0

+3

Two Year Chart

02-May-22 -- 01-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
17-Aug-23 4:30 PM View:	15-Aug-23 Grant 0	Naos Yaron Sr. VP, Operations		Protalix BioTherapeutics, Inc. - PLX	910% 20.59K to 207.93K	0	0	--	--	Show Txns Hide Txns

03-Apr-24 5:30 PM View:	01-Apr-24 Grant 0	Bashan Dror President and CEO Director		Protalix BioTherapeutics, Inc. - PLX	98% 1.15M to 2.28M	0	0	--	--	Show Txns Hide Txns

17-Aug-23 4:30 PM View:	15-Aug-23 Grant 0	Rubin Eyal Sr. VP and CFO		Protalix BioTherapeutics, Inc. - PLX	55% 368.1K to 570.0K	0	0	--	--	Show Txns Hide Txns

17-Aug-23 4:30 PM View:	15-Aug-23 Grant 0	Hayon Yael VP, Research & Development		Protalix BioTherapeutics, Inc. - PLX	100% 0 to 35.12K	0	0	--	--	Show Txns Hide Txns